About Biological Mimetics
Biological Mimetics is a company based in Frederick (United States) founded in 1996.. Biological Mimetics offers products and services including IRT Technology and FAST Diagnostics. Biological Mimetics operates in a competitive market with competitors including Vir Biotechnology, Vaxcyte, Cidara Therapeutics, Freeline and Altimmune, among others.
- Headquarter Frederick, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biological Mimetics, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$297.76 K (USD), Grant
Jun 01, 2024
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biological Mimetics
Biological Mimetics offers a comprehensive portfolio of products and services, including IRT Technology and FAST Diagnostics. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Bioinformatic tool for identifying epitopes to improve vaccine responses.
Multi-chambered device for simple CRISPR nucleic acid detection.
Funding Insights of Biological Mimetics
- Total Funding Total Funding
- Total Rounds 11
- Last Round Grant — $297,761
-
First Round
First Round
(01 Nov 2009)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2024 | Amount | Grant - Biological Mimetics | Valuation |
investors |
|
| Sep, 2023 | Amount | Grant - Biological Mimetics | Valuation |
investors |
|
| Jul, 2023 | Amount | Grant - Biological Mimetics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Biological Mimetics
Biological Mimetics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include United States Department of Agriculture. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Leadership is provided on agriculture, food, and rural development matters.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Biological Mimetics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Biological Mimetics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biological Mimetics Comparisons
Competitors of Biological Mimetics
Biological Mimetics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Vir Biotechnology, Vaxcyte, Cidara Therapeutics, Freeline and Altimmune, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of therapeutics for the treatment of infectious diseases
|
|
| domain | founded_year | HQ Location |
Vaccines for infectious diseases are developed using cell-free protein synthesis.
|
|
| domain | founded_year | HQ Location |
Novel anti-infectives for bacterial and fungal infections are developed.
|
|
| domain | founded_year | HQ Location |
Gene therapy platform is developed for chronic disease treatments.
|
|
| domain | founded_year | HQ Location |
Vaccines for infectious diseases and solid tumors are developed.
|
|
| domain | founded_year | HQ Location |
Prophylactic vaccines for infectious diseases are developed and advanced.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Biological Mimetics
When was Biological Mimetics founded?
Biological Mimetics was founded in 1996 and raised its 1st funding round 13 years after it was founded.
Where is Biological Mimetics located?
Biological Mimetics is headquartered in Frederick, United States. It is registered at Frederick, Maryland, United States.
Who is the current CEO of Biological Mimetics?
Peter Nara is the current CEO of Biological Mimetics.
What does Biological Mimetics do?
Founded in 1996 and based in Frederick, United States, Biological Mimetics is involved in the biotechnology sector, focusing on vaccine development and commercialization for challenging targets including viruses, bacteria, parasites, and cancer. Immune Refocusing Technology is utilized to address deceptive imprinting, an evasion mechanism employed by pathogens. Applications target infections such as dengue, malaria, polio, and HIVAIDS.
Who are the top competitors of Biological Mimetics?
Biological Mimetics's top competitors include Vaxcyte, Serum Institute of India and Biological E.
What products or services does Biological Mimetics offer?
Biological Mimetics offers IRT Technology and FAST Diagnostics.
Who are Biological Mimetics's investors?
Biological Mimetics has 1 investor. Key investors include United States Department of Agriculture.